Skip to main content

Table 2 Baseline characteristics, treatment, and clinical outcomes of the study population

From: Validation of a new risk score system for non-variceal upper gastrointestinal bleeding

Patient related factorAll patients (n = 905)
Characteristics
Sex
 Male674 (74.5%)
 Female231 (25.5%)
Age, years65.4 ± 14.7
 < 65397 (43.9%)
 ≥65508 (56.1%)
Alcohol
 Never505 (55.8%)
 Past29 (3.1%)
 Present371 (41.0%)
Smoking
 Never473 (52.3%)
 Past219 (24.2%)
 Present213 (23.5%)
ASA score 3488 (53.9%)
ASA score 496 (10.6%)
Comorbidity
 Diabetes mellitus251 (27.7%)
 Hypertension453 (50.1%)
 Angina81 (9.0%)
 Cerebral infarction156 (17.2%)
 ARDS28 (3.1%)
 Disseminated malignancy87 (9.6%)
 Liver cirrhosis67 (7.4%)
 Sepsis29 (3.2%)
 DIC26 (2.9%)
Chief complaint at first visit
 Melena453 (50.1%)
 Hematemesis282 (31.2%)
 Syncope43 (4.8%)
 Hematochezia66 (7.3%)
 Anemia20 (2.2%)
 Dizziness28 (3.1%)
 Others13 (1.4%)
Endoscopic findings of acute NVUGIB
 Gastric ulcer614 (67.8%)
 Duodenal ulcer175 (19.3%)
 Gastroduodenal ulcer11 (1.21%)
 Esophageal ulcer7 (0.77%)
 Mallory-Weiss syndrome47 (5.19%)
 AGML4 (0.44%)
 Angiodysplasia22 (2.43%)
 Hemorrhagic gastritis12 (1.32%)
 Cancer-related bleeding13 (1.76%)
 Forrest classification (IA, IB, IIA)607 (67.0%)
 Forrest classification (IIB, IIC, III)298 (32.9%)
Outcomes
 Admission before 8 h467 (51.6%)
 Admission day (mean)8.779 day
 Endoscopy failure at first admission35 (3.9%)
 Endoscopic hemostasis therapy735 (81.2%)
 Endoscopic hemostasis failure52 (7.0%)
 Re-bleeding at 2nd endoscopy128 (14.1%)
 All-cause mortality in hospital in 30 days44 (4.9%)
  1. Data are presented as mean ± SD, number (%), or mean (range)
  2. NVUGIB Non-variceal upper gastrointestinal bleeding, ASA The American Society of Anesthesiology classification, ARDS Acute respiratory distress syndrome, DIC Disseminated intravascular coagulation, AGML Acute gastric mucosal Lesion